Free tool
Diagnostics stocks
We cover 107 companies grouped under the Diagnostics theme. The median market value in the group is $54.74M. Across the group, the median move over the past trading day is −0.62%. 34% of the 104 with a 200-day average trade above it. Price change over the past year runs from −79.0% to +57.3% across the middle 80 percent of the group, with a median of −15.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
107 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| GH | Guardant Health, Inc. | $170.92 | +19.01% | +68.00% | +169.17% |
| ESF0.DE | Eurofins Scientific SE | 72.70 EUR | +7.58% | +17.51% | +12.65% |
| TEM | Tempus AI, Inc. | $68.48 | +59.63% | +9.81% | −6.49% |
| BIM.PA | bioMérieux S.A. | 75.50 EUR | +3.64% | −31.05% | −35.91% |
| PSNL | Personalis, Inc. | $17.08 | +43.77% | +117.58% | +257.32% |
| DIA.WA | Diagnostyka S.A. | 167.60 PLN | +0.72% | −3.07% | −17.76% |
| 4544.T | H.U. Group Holdings, Inc. | 3,634.00 JPY | +1.08% | +8.30% | +2.77% |
| OPK | OPKO Health, Inc. | $1.51 | −8.48% | +18.90% | +6.34% |
| CSTL | Castle Biosciences, Inc. | $34.08 | +42.65% | −11.57% | +52.96% |
| QDEL | QuidelOrtho Corporation | $14.91 | −10.56% | −48.19% | −46.31% |
| 4694.T | BML, Inc. | 3,625.00 JPY | −2.03% | −3.47% | +5.42% |
| IDX.AX | Integral Diagnostics Limited | 2.30 AUD | +10.05% | −7.10% | −19.60% |
| DASA3.SA | Diagnósticos da América S.A. | 2.61 BRL | −1.51% | −41.74% | +93.33% |
| FLGT | Fulgent Genetics, Inc. | $19.81 | +0.92% | −22.59% | −8.46% |
| 137310.KS | SD Biosensor, Inc. | 6,140.00 KRW | +1.66% | −30.67% | −38.35% |
| 4549.T | Eiken Chemical Co., Ltd. | 2,296.00 JPY | −8.71% | −3.54% | −5.16% |
| CEVI.ST | CellaVision AB (publ) | 164.00 SEK | +7.47% | +10.88% | −5.28% |
| NIOX.L | NIOX Group Plc | 66.60 GBP | +8.82% | −2.03% | −9.49% |
| VOX.WA | Voxel S.A. | 134.20 PLN | +6.85% | +10.36% | −18.11% |
| ACL.AX | Australian Clinical Labs Limited | 2.81 AUD | +15.64% | +4.75% | +5.46% |
| N3B.F | Anbio Biotechnology | 6.40 EUR | −24.26% | −62.13% | −83.42% |
| NNNN | Anbio Biotechnology | $7.72 | −23.94% | −73.81% | −83.55% |
| 0KCC.L | Insight Molecular Diagnostics Inc. | $4.36 | +1.16% | −37.34% | +77.61% |
| 197A.T | TAUNS LABORATORIES INC. | 504.00 JPY | +4.56% | −0.59% | −11.13% |
| SBS.DE | Stratec SE | 22.85 EUR | +11.46% | +3.39% | −16.91% |
| IDHC.L | Integrated Diagnostics Holdings plc | $0.55 | −9.00% | −21.91% | +16.89% |
| MYGN | Myriad Genetics, Inc. | $3.12 | −41.35% | −49.19% | −47.39% |
| OSUR | OraSure Technologies, Inc. | $3.71 | −7.71% | +55.88% | +11.08% |
| HLS.AX | Healius Limited | 0.45 AUD | +20.00% | −50.55% | −50.55% |
| ALERS.PA | Eurobio Scientific Société anonyme | 19.80 EUR | −6.60% | −18.01% | −21.89% |
| 4595.T | Mizuho Medy Co.,Ltd. | 1,721.00 JPY | +1.59% | −0.58% | +11.63% |
| LUCD | Lucid Diagnostics Inc. | $0.97 | +6.20% | −13.33% | −22.96% |
| PEB.AX | Pacific Edge Limited | 0.20 AUD | −9.09% | +25.00% | +60.00% |
| S2B.WA | Syn2bio S.A. | 63.00 PLN | −9.12% | +76.47% | +76.47% |
| 0ELV.L | Guerbet SA | 7.80 EUR | −1.64% | −48.00% | −62.50% |
| EKF.L | EKF Diagnostics Holdings plc | 24.70 GBP | −5.00% | −6.97% | −15.56% |
| IMDX | Insight Molecular Diagnostics Inc. | $4.30 | −6.72% | −39.94% | +73.39% |
| PCSC | Perceptive Capital Solutions Corp | $11.95 | +0.67% | −8.08% | +13.38% |
| SCP.WA | Scope Fluidics S.A. | 140.20 PLN | +19.83% | +0.29% | −9.90% |
| S84.F | Scope Fluidics S.A. | 27.90 EUR | +19.74% | −25.50% | −10.43% |
| QUCY | Quantum Cyber N.V. | $1.38 | +26.15% | +18.53% | −15.12% |
| BNR | Burning Rock Biotech Limited | $10.44 | +13.60% | −46.95% | +22.54% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | 59.70 SEK | −12.97% | −47.45% | −60.78% |
| BIOPOR.CO | BioPorto A/S | 1.24 DKK | +2.48% | +19.00% | −3.13% |
| 7V0.DE | Novogenia AG | 6.40 EUR | +7.56% | −16.34% | −25.00% |
| 6678.T | Techno Medica Co., Ltd. | 2,112.00 JPY | +3.63% | −0.76% | +12.34% |
| AALR3.SA | Alliança Saúde e Participações S.A. | 2.96 BRL | −8.36% | −36.34% | −52.03% |
| BB1.AX | BLINKLAB FPO [BB1] | 0.80 AUD | +23.26% | −3.64% | +47.22% |
| SERA | Sera Prognostics, Inc. | $2.09 | +2.96% | −30.33% | −26.41% |
| MDXH | MDxHealth SA | $0.76 | +83.97% | −77.96% | −84.51% |
| LDX.AX | Lumos Diagnostics Holdings Limited | 0.10 AUD | 0.00% | −68.75% | −25.93% |
| KVAC | Keen Vision Acquisition Corp | $12.01 | −3.92% | +2.21% | +3.36% |
| DXR | Daxor Corporation | $10.03 | −5.87% | −30.19% | −11.60% |
| ALKLH.PA | Klea Holding SA | 0.15 EUR | −4.73% | −31.24% | −32.00% |
| CYC.AX | Cyclopharm Limited | 0.52 AUD | −13.11% | −47.51% | −48.30% |
| BIOBV.HE | Biohit Oyj | 2.60 EUR | −6.14% | −27.78% | −8.13% |
| 0DRP.L | Biohit Oyj | 2.60 EUR | −5.63% | −6.31% | −6.31% |
| ABLD.PA | ABL Diagnostics Société anonyme | 2.40 EUR | −2.44% | −37.50% | −46.67% |
| ALNOV.PA | Novacyt S.A. | 0.51 EUR | +16.21% | +21.19% | +7.38% |
| PAVM | PAVmed Inc. | $5.32 | −1.12% | −27.42% | −63.21% |
| NCYT.L | Novacyt S.A. | 43.50 GBP | +17.73% | +21.00% | +7.81% |
| 2385.T | Soiken Holdings Inc. | 224.00 JPY | +3.70% | −5.49% | +17.28% |
| ABDX.L | Abingdon Health Plc | 10.75 GBP | +4.88% | +67.97% | +104.76% |
| COV.AX | Cleo Diagnostics Ltd | 0.35 AUD | +12.90% | −43.09% | +4.48% |
| ACARIX.ST | Acarix AB (publ) | 0.24 SEK | −3.99% | −10.93% | −14.11% |
| NXN.AX | Nexsen Ltd | 0.21 AUD | −12.50% | +40.00% | −25.00% |
| MBX.TO | Microbix Biosystems Inc. | 0.31 CAD | −1.61% | +27.08% | +27.08% |
| GDR.L | genedrive plc | 1.30 GBP | +33.33% | +48.57% | +67.74% |
| MAP.AX | Microba Life Sciences Limited | 0.06 AUD | +17.02% | −28.57% | −42.11% |
| NN6.DE | NanoRepro AG | 1.85 EUR | −5.38% | +19.81% | −4.90% |
| ALIKO.PA | Ikonisys S.A. | 1.42 EUR | −5.33% | −12.07% | −6.58% |
| RHY.AX | Rhythm Biosciences Limited | 0.10 AUD | +23.46% | −20.00% | 0.00% |
| 6090.T | Human Metabolome Technologies, Inc. | 623.00 JPY | +4.53% | −7.01% | −16.38% |
| PIQ.AX | Proteomics International Laboratories Ltd | 0.17 AUD | +10.00% | −77.08% | −48.44% |
| CLBX.L | CelLBxHealth plc | 1.25 GBP | −1.96% | +13.64% | −79.17% |
| ALBIO.PA | Biosynex SA | 0.90 EUR | −0.88% | +56.06% | −23.23% |
| 4241.T | atect corporation | 661.00 JPY | +10.17% | +29.20% | +55.58% |
| URT.WA | Urteste S.A. | 43.70 PLN | −6.42% | +2.82% | −15.31% |
| BDX.AX | BCAL Diagnostics Limited | 0.06 AUD | −17.81% | −40.00% | −6.25% |
| IIQ.AX | INOVIQ Ltd | 0.17 AUD | −12.82% | −57.50% | −58.54% |
| GMT.WA | Genomtec S.A. | 3.68 PLN | −8.80% | −2.39% | −40.65% |
| ADVB | Advanced Biomed Inc. | $9.24 | −15.07% | +52.98% | +13.24% |
| BIOVIC-B.ST | Biovica International AB (publ) | 0.45 SEK | −9.46% | +4.41% | −30.12% |
| TRI.AX | TrivarX Limited | 0.02 AUD | 0.00% | −20.00% | +60.00% |
| BACTIQ.CO | BactiQuant A/S | 2.32 DKK | −0.43% | −37.47% | −10.42% |
| BOUL.ST | Boule Diagnostics AB (publ) | 3.19 SEK | −12.36% | −39.58% | −47.36% |
| CRM.WA | PZ Cormay S.A. | 0.52 PLN | 0.00% | +27.32% | +3.16% |
| BMX.WA | BioMaxima S.A. | 10.14 PLN | +1.71% | −17.89% | −20.78% |
| AT1.AX | Atomo Diagnostics Limited | 0.02 AUD | 0.00% | −57.50% | −5.56% |
| GENI.L | GENinCode Plc | 0.90 GBP | +12.50% | −62.50% | −35.71% |
| ACE.ST | Ascelia Pharma AB (publ) | 0.61 SEK | +16.48% | −81.26% | −88.08% |
| CODX | Co-Diagnostics, Inc. | $1.25 | −11.35% | −77.52% | −87.22% |
| NDRA | ENDRA Life Sciences Inc. | $5.44 | +21.97% | +26.81% | +32.36% |
| AIDX | 20/20 Biolabs, Inc. | $0.56 | +22.39% | −97.64% | −97.64% |
| ACON | Aclarion, Inc. | $2.39 | +12.21% | −52.01% | −66.10% |
| OBD.L | Oxford BioDynamics Plc | 0.12 GBP | −1.60% | −50.80% | −74.11% |
| INBS | Intelligent Bio Solutions Inc. | $2.26 | +41.78% | −71.36% | −85.79% |
| IBX.AX | Imagion Biosystems Limited | 0.01 AUD | −16.67% | −61.54% | −37.50% |
| CDIO | Cardio Diagnostics Holdings, Inc. | $1.93 | +23.72% | −32.04% | −48.46% |
| BMRA | Biomerica, Inc. | $1.69 | +5.62% | −33.21% | −46.35% |
| ALPRE.PA | Predilife S.A. | 1.11 EUR | −7.50% | −64.98% | −65.74% |
| BGLC | BioNexus Gene Lab Corp. | $1.43 | +5.93% | −63.71% | −74.42% |
| REVB | Revelation Biosciences, Inc. | $0.96 | −8.00% | −70.63% | −91.25% |
| ONCO | Onconetix, Inc. | $0.64 | −22.77% | −99.20% | −99.56% |
| VRAX | Virax Biolabs Group Limited | $2.77 | −4.15% | +621.35% | +365.55% |
| BJDX | Bluejay Diagnostics, Inc. | $0.89 | −10.66% | −65.90% | −83.70% |
| 0G8X.L | Immunovia AB (publ) | 0.15 SEK | −11.14% | −33.92% | −78.96% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.